Beijing Airdoc Technology Co., Ltd. (HKG:2251)

Market Cap	1.23B +13.4%
Revenue (ttm)	160.39M -32.0%
Net Income	-193.55M
EPS	-1.90
Shares Out	102.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,000
Average Volume	33,320
Open	11.81
Previous Close	11.81
Day's Range	11.41 - 12.00
52-Week Range	10.00 - 16.00
Beta	0.74
RSI	41.77
Earnings Date	Mar 27, 2026

About Beijing Airdoc Technology

Beijing Airdoc Technology Co., Ltd. provides artificial intelligence (AI) empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally. The company offers a software as a medical device (SaMD) product, Airdoc-AIFUNDUS, which is an AI-assisted diagnosis of retinal detection product that is available in three versions comprising version 1.0 for the diagnosis of diabetic retinopathy, version 2.0 that address various fundus diseases, and version 3.0 for the diagnosis of pathological m...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 193
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2251

Financial Performance

In 2024, Beijing Airdoc Technology's revenue was 156.37 million, a decrease of -23.34% compared to the previous year's 203.96 million. Losses were -255.46 million, 92.8% more than in 2023.

Financial numbers in CNY